| Literature DB >> 33261663 |
Larissa Almeida Martins1,2, Giuseppe Palmisano1, Mauro Cortez1, Rebeca Kawahara1,3, José Mario de Freitas Balanco1, André Fujita4, Beatriz Iglesias Alonso1, Darci Moraes Barros-Battesti5, Gloria Regina Cardoso Braz6, Lucas Tirloni7, Eliane Esteves1, Sirlei Daffre1, Andréa Cristina Fogaça8.
Abstract
BACKGROUND: Rickettsia rickettsii is a tick-borne obligate intracellular bacterium that causes Rocky Mountain spotted fever, a life-threatening illness. To obtain an insight into the vector-pathogen interactions, we assessed the effects of infection with R. rickettsii on the proteome cells of the tick embryonic cell line BME26.Entities:
Keywords: Apoptosis; Proteome; Rickettsiae; Tick
Mesh:
Substances:
Year: 2020 PMID: 33261663 PMCID: PMC7706286 DOI: 10.1186/s13071-020-04477-5
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Fig. 1Functional classification of tick proteins modulated by Rickettsia rickettsii infection. Bars represent the total of proteins within each functional category that were upregulated (blue bars) or downregulated (red bars) at 6 (a) and 48 h (b) post-infection with R. rickettsii
Selected proteins upregulated at 6 or 48 h post-Rickettsia rickettsii infection of BME26 cells
| Functional classi of proteins | 6 h post-infection | 48 h post-infection | ||
|---|---|---|---|---|
| ID | Annotation | ID | Annotation | |
ST/ APOPTOSIS | BME26USP-64008 | Apoptotic chromatin condensation inducer in the nucleus | BME26USP-3827 | Mucin-1—Negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| BME26USP-77602 | Fanconi anemia complementation group D2—negative regulation of apoptotic process | |||
| BME26USP-73913 | Cytokine-induced apoptosis inhibitor 1 | |||
| PROT | BME26USP-3792 | Small ubiquitin-related modifier 3 | BME26USP-63775 | 26S Proteasome regulatory complex subunit RPN11 |
| BME26USP-1981 | 20S Proteasome regulatory subunit alpha type PSMA5/PUP2 | BME26USP-4899 | 20S Proteasome regulatory subunit beta type PSMB1/PRE7 | |
| BME26USP-61379 | 26S Proteasome regulatory complex subunit RPN12/PSMD8 | |||
| BME26USP-61464 | 26S Proteasome regulatory complex ATPase RPT5 | BME26USP-66020 | Ubiquitin-protein ligase | |
| BME26USP-63407 | proteasome inhibitor | |||
| BME26USP-67891 | 26S Proteasome regulatory complex subunit RPN7/PSMD6 | BME26USP-68301 | 20S Proteasome regulatory subunit alpha type PSMA1/PRE5 | |
| BME26USP-70300 | 26S Proteasome regulatory complex subunit RPN5/PSMD12 | |||
| CS | BME26USP-SigP-75480 | Tyrosine protein kinase receptor tie-1 | BME26USP-2996 | Microtubule-associated protein partial |
| BME26USP-71952 | Actin-related protein arp2/3 complex subunit arpc5 | BME26USP-5135 | Tropomodulin and leiomodulin | |
| BME26USP-71823 | Microtubule-binding protein | BME26USP-65063 | Src substrate cortactin | |
| BME26USP-26177 | Ca2+-Binding actin-bundling protein (spectrin) alpha chain | BME26USP-42758 | Vinculin—Neuron projection morphogenesis/phagocytosis/actin/cytoskeleton/structural molecule/actin binding/cytoskeletal anchoring | |
| BME26USP-69366 | Alpha tubulin | |||
ST/Apoptosis, Signal transduction and apoptosis; PROT, proteasome machinery; CS, cytoskeletal functional classes, SRC
Selected proteins downregulated at 6 or 48 h post-R. rickettsii infection of BME26 cells
| Functional class of proteins | 6 h post-infection | 48 h post-infection | ||
|---|---|---|---|---|
| ID | Annotation | ID | Annotation | |
ST/ APOPTOSIS | BME26USP-3827 | Mucin-1—Negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | – | – |
| BME26USP-65523 | Apoptosis inhibitor 5/fibroblast growth factor 2-interacting factor 2 | |||
| BME26USP-74870 | Clathrin assembly protein AP180 | |||
| BME26USP-4568 | Ubiquinone oxidoreductase b16.6 subunit/cell death | |||
| PROT | BME26USP-65609 | 20S Proteasome regulatory subunit beta type PSMB4/PRE4 | BME26USP-65272 | SCF ubiquitin ligase Skp1 component |
| BME26USP-64301 | 26S Proteasome regulatory complex ATPase RPT6 | |||
| BME26USP-75557 | 20S Proteasome regulatory subunit alpha type PSMA2/PRE8 | |||
| BME26USP-4899 | 20S Proteasome regulatory subunit beta type PSMB1/PRE7 | |||
| BME26USP-77519 | 26S Proteasome regulatory complex subunit RPN10/PSMD4 | |||
| BME26USP-23319 | ATP-dependent Lon protease | |||
| CS | BME26USP-75222 | Alpha tubulin | BME26USP-26191 | Protein tyrosine kinase |
| BME26USP-71918 | Actin-related protein Arp2/3 complex subunit Arp2 | |||
| BME26USP-62031 | Cdc42 homolog/positive regulation of protein kinase/maintenance of protein location/adherens junction | |||
| BME26USP-2688 | GDP dissociation inhibitor/microtubule-associated complex/protein transport/Rab GDP-dissociation inhibitor | BME26USP-SigP-76633 | Tyrosine kinase eph ephrin receptor family | |
| BME26USP-4897 | Actin-related protein Arp2/3 complex subunit ARPC1/p41-ARC | |||
| BME26USP-25990 | Dynein light intermediate chain | |||
| BME26USP-77773 | Microtubule-actin cross-linking factor 1 | |||
ST/apoptosis: signal transduction and apoptosis; PROT: proteasome machinery; CS: cytoskeletal functional classes, SCF, Skp1/Cullin/F-box containing complex
Fig. 2Caspase-3 activity in cells of the Rhipicephalus microplus (Canestrini) BME26 and Amblyomma sculptum (Berlese) embyronic cell lines (BME26 and IBU/ASE-16, respectively) exposed to either viable or thermo-inactivated R. rickettsii. The activity of caspase-3, induced or not by staurosporine, was evaluated in BME26 (a) and IBU/ASE-16 (b) cells exposed to viable (red bars) or thermo-inactivated (green bars) R. rickettsii. As a control, caspase-3 activity was determined in noninfected cells (blue bars). Forty-eight hours after exposure, the enzymatic activity was determined by measuring the release of the AMC fluorescent cleavage product from the synthetic fluorogenic substrate Ac-DEVD-AMC (emission excitation: 380–460 nm). The relative activity of caspase-3 (in units of arbitrary fluorescence [UAF]) represents the ratio of ΔUAF (UAF60 min − UAF0 min) of each condition to the ΔUAF of noninfected cells treated with 400 nM staurosporine. Error bars: ± standard deviation of six measurements (n = 6). Asterisks indicate significant difference at *P < 0.05 and **p < 0.001 (Student’s t-test)
Fig. 3Phosphatidylserine externalization in BME26 cells exposed to either viable or thermo-inactivated R. rickettsii. Noninfected BME26 cells (control) or cells exposed for 48 h to either viable or thermo-inactivated R. rickettsii were treated with 400 nM staurosporine. After 6 h, cells were labeled with propidium iodide (red), annexin-V (green) and Hoechst (blue), and observed under a fluorescence microscope. a The panel at the top represents the three conditions at 40× magnification. The square areas outlined with broken lines are those areas presented in the images below the top panel, for better visualization. The light-blue arrows indicate annexin-V staining. Bar: 40 μm. b The graph represents the number of cells labeled with each probe in three independent images of each of the three biological replicates. Error bars: ± standard deviation. Asterisk indicates significant difference at *P < 0.001 (Student’s t-test)
Fig. 4Growth curve of R. rickettsii in BME26 cells treated with either staurosporine or the caspase-3 inhibitor Z-DEVD-Fmk. BME26 cells were treated with staurosporine (400 nM) or the caspase-3 inhibitor Z-DEVD-Fmk (10 μM). Untreated cells served as the control. After 1 h, cells were inoculated with R. rickettsii. The number of rickettsiae after 6, 24, 48, 72, 96 and 120 h was determined by quantitative PCR using specific primers and a hydrolysis probe for the single-copy gene gltA of Rickettsia spp. aSignificant difference in rickettsial growth in cells treated with Z-DEVD-Fmk (P < 0.02, Student’s t-test),b significant difference in rickettsial growth in cells treated with staurosporine (P < 0.007, Student’s t-test), compared to the control. Error bars: ± standard deviation (n = 3)